Amgen Europe B.V.

• B02 - Antihemorrágicos
• NPLATE powder for solution for injection 250 µg
• NPLATE powder for solution for injection 250 µg / 500 µg
• NPLATE powder for solution for injection 500 µg
• B03 - Preparados antianémicos
• ARANESP solution for injection 10 µg/0.4 ml
• ARANESP solution for injection 40 µg/0.4 ml
• ARANESP solution for injection 500 µg/1 ml
• ARANESP solution for injection 60 µg/0.3 ml
• C10 - Agentes modificadores de los lípidos
• REPATHA solution for injection 140 mg/ ml
• REPATHA solution for injection 420 mg
• H05 - Homeostasis del calcio
• MIMPARA film-coated tablet 30 mg
• MIMPARA granules 1 mg
• MIMPARA granules 2.5 mg
• MIMPARA granules 5 mg
• PARSABIV solution for injection 10 mg/2 ml
• PARSABIV solution for injection 2.5 mg/0.5 ml
• PARSABIV solution for injection 5 mg/1 ml
• L01 - Antineoplásicos
• BLINCYTO powder for solution for infusion 12.5 µg/ml
• IMLYGIC solution for injection 1 000 000 PFU/ml
• IMLYGIC solution for injection 100 000 000 PFU/ml
• KANJINTI powder for solution for infusion 150 mg
• KANJINTI powder for solution for infusion 420 mg
• KYPROLIS powder for solution for infusion 60 mg
• VECTIBIX concentrate for solution for infusion 100 mg/5 ml
• L03 - Inmunoestimulantes
• NEULASTA solution for injection 6 mg/0.6 ml
• NEUPOGEN SINGLEJECT PREFILLED SYRINGE solution for injection 300 µg(30 M IU) 0.6 mg/1 ml
• NEUPOGEN SINGLEJECT PREFILLED SYRINGE solution for injection 480 µg(48 M IU) 0.96 mg/1 ml
• NEUPOGEN solution for injection 300 µg(30 M IU) 0.3 mg/ml
• L04 - Inmunosupresores
• AMGEVITA PREFILLED SYRINGE solution for injection 20 mg/0.4 ml
• AMGEVITA PREFILLED SYRINGE solution for injection 40 mg/0.8 ml
• OTEZLA film-coated tablet 10 mg - 20 mg - 30 mg
• OTEZLA film-coated tablet 30 mg
• M05 - Preparados para el tratamiento de enfermedades óseas
• PROLIA solution for injection 60 mg/1 ml
• XGEVA solution for injection 120 mg/1.7 ml